Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $87.9900 (-0.01%) ($87.5650 - $88.5300) on Tue. Jan. 21, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.12% (three month average) | RSI | 49 | Latest Price | $87.9900(-0.01%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.1% a day on average for past five trading days. | Weekly Trend | ABBV declines -0.3% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(63%) SPLV(53%) VYM(53%) DIA(52%) IVE(51%) | Factors Impacting ABBV price | ABBV will decline at least -0.56% in a week (0% probabilities). VIXM(-36%) VXX(-14%) TLT(-14%) IGOV(-5%) UUP(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.56% (StdDev 1.12%) | Hourly BBV | 0.2 () | Intraday Trend | -0% | | | |
|
Resistance Level | $89.08 | 5 Day Moving Average | $88.54(-0.62%) | 10 Day Moving Average | $88.87(-0.99%) | 20 Day Moving Average | $89.08(-1.22%) | To recent high | -2.5% | To recent low | 15% | Market Cap | $155.239b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |